TipHub

422.55

+8.16 +1.97%

As of 27 Jul 2026 · delayed

NSE Listed

Panacea Biotec Ltd. (PANACEABIO)

Volume: 1,25,042Avg Vol 1W: 3,87,747.2Avg Vol 1M: 2,36,007.252W Range:292.4647
Key Ratios
Checked 1d ago
Market Cap₹2,655 Cr
Current Price₹422.55
Previous Close₹414.39
High / Low (52w)₹647 / ₹292.4
Volume1,25,042
Avg Vol (1W)3,87,747.2
Avg Vol (1M)2,36,007.2
Stock P/E5,417.5
Book Value₹136.19
Dividend Yield0%
ROE-2.9%
ROA-0.6%
Revenue (TTM)₹580 Cr
Revenue Growth0%
Profit Margin-0.8%
Total Debt₹15 Cr
Shares Outstanding6 Cr
Face Value₹1
EPS (TTM)₹0.08
P/B3.18
Debt / Equity0.03
50 DMA₹519.56
200 DMA₹407.53
Day change+1.97%
Price Chart
422.55 0.49% · 1Y
6082962.4Cr
2025-07-29
2026-07-27

20-day avg volume: 2.4L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 30% YoY.
Cons
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 5418.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹116 Cr₹147 Cr₹163 Cr₹133 Cr₹167 Cr₹141 Cr₹165 Cr₹167 Cr
EBITDA₹-19 Cr₹3 Cr₹3 Cr₹-27 Cr₹-4 Cr₹-20 Cr₹6 Cr₹-3 Cr
Net Profit₹-16 Cr₹5 Cr₹5 Cr₹-2 Cr₹4 Cr₹-14 Cr₹4 Cr₹1 Cr
EPS
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹77 Cr₹108 Cr₹580 Cr₹68 Cr₹112 Cr₹91 Cr₹99 Cr₹111 Cr
EBITDA₹5 Cr₹14 Cr₹-40 Cr₹-17 Cr₹-3 Cr₹-15 Cr₹-2 Cr₹2 Cr
Net Profit₹1 Cr₹10 Cr₹-8 Cr₹-12 Cr₹-7 Cr₹-16 Cr₹-7 Cr₹0 Cr
EPS-1.37
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹1,608 Cr₹1,376 Cr₹1,390 Cr₹1,178 Cr₹1,759 Cr₹1,271 Cr₹1,241 Cr₹1,290 Cr
Total Liabilities₹1,302 Cr₹1,028 Cr₹1,195 Cr₹1,409 Cr₹885 Cr₹431 Cr₹402 Cr₹459 Cr
Equity₹306 Cr₹347 Cr₹196 Cr₹-232 Cr₹874 Cr₹840 Cr₹838 Cr₹831 Cr
Total Debt
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹122 Cr₹103 Cr₹-22 Cr₹108 Cr₹295 Cr₹-420 Cr₹2 Cr₹-26 Cr
Investing₹55 Cr₹-5 Cr₹-35 Cr₹-48 Cr₹1,283 Cr₹430 Cr₹10 Cr₹65 Cr
Financing₹-164 Cr₹-101 Cr₹91 Cr₹-47 Cr₹-1,176 Cr₹-18 Cr₹-3 Cr₹-3 Cr
Free Cash Flow₹122 Cr₹103 Cr₹-22 Cr₹108 Cr₹295 Cr₹-420 Cr₹2 Cr₹-26 Cr
Shareholding
Promoter 72.48% Institutions 4.56% Public 22.96%
Efficiency & Working Capital
ROCE0%
Interest Coverage-10.1
Dividend Payout
Debtor Days47 d
Inventory Days139 d
Payable Days147 d
Cash Conversion Cycle39 d
Working Capital Days187 d
Shareholding Details

As of 2026-06-30

Promoter72.5%
FII2.3%
DII2.3%
Institutions4.6%
Public23%
Promoter Pledge0%
No. of Shareholders33,532
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters73.6%73.6%73.6%73.5%72.9%72.5%72.5%72.5%72.5%72.5%72.5%72.5%
FIIs0.3%0.3%0.3%0.3%0.4%0.4%1.2%0.8%1.1%1.4%1.6%2.3%
DIIs0%0%0.8%1.1%1.2%1.2%1.5%1.5%1.8%1.9%2%2.3%
Public26.1%26.1%25.3%25.2%25.6%26%24.9%25.2%24.7%24.3%24%23%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders48,87847,09146,24245,51339,98235,44633,59334,25633,59334,59732,62033,532
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Dr. Rajesh JainShareholding of Promoter and Promoter Group49%3.00 Cr
Mr. Sandeep JainShareholding of Promoter and Promoter Group15.3%93,51,924
Mrs. Nirmala JainShareholding of Promoter and Promoter Group4.1%25,11,000
First Lucre Partnership Co.Shareholding of Promoter and Promoter Group3.7%22,55,815
Massachusetts Institute Of TechnologyPublic Shareholding1.7%10,50,000
Viral Amal ParikhPublic Shareholding1.5%8,99,341
Rajesh Jain (huf) (karta : Rajesh Jain)Shareholding of Promoter and Promoter Group0.3%2,00,000
Second Lucre Partnership Co.Shareholding of Promoter and Promoter Group0.1%57,639
Sandeep Jain (huf) (karta : Sandeep Jain)Shareholding of Promoter and Promoter Group0%0
Mr. Abhey Kumar JainShareholding of Promoter and Promoter Group0%0
Mr. Ashish JainShareholding of Promoter and Promoter Group0%500
Mrs. Meena JainShareholding of Promoter and Promoter Group0%0
Mrs. Pamilla JainShareholding of Promoter and Promoter Group0%0
Mr. Ankesh JainShareholding of Promoter and Promoter Group0%0
Mr. Harshet JainShareholding of Promoter and Promoter Group0%0
Mrs. Priyanka JainShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Rajesh JainChairman / Executive Director / M D / Promoter2025
Sandeep JainED / Joint MD / Promoter2025
Ankesh JainWTD & Executive Director2025
Harshet JainWTD & Executive Director2025
Sanjay TrehanExecutive Director / WTD - Technical2025
Ambika SharmaIndependent Non Exe. Director2025
Krishan Kumar JalanIndependent Non Exe. Director2025
Rajesh JainIndependent Non Exe. Director2025
Rajender Pal SinghIndependent Non Exe. Director2025
Venkatesh SarvasiddhiIndependent Non Exe. Director2025
Vinod GoelCS / Compliance Officer / Group CFO / Head - Legal2025
Segments — Product
SegmentRevenueShare
Vaccines₹96 Cr21.7%
Formulations₹348 Cr78.3%
Research and Development₹0 Cr0%
Segments — Geography
RegionRevenueShare
Domestic₹79 Cr82.3%
Overseas₹17 Cr17.7%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹11366
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20253880060394
20252300000230
20251440060150
Insider / Designated-Person Trades

3 recent disclosure(s)

Dr. Rajesh JainDisposal · 2,00,000
Rajesh Jain HUFAcquisition · 2,00,000
Nosheen SheikhAcquisition · 3,000
Substantial Acquisitions (SAST)

1 disclosure(s)

NULL12/06/2026 · 2,00,000
Company Information
Incorporated1984
ChairmanRajesh Jain
AuditorSuresh Surana & Associates LLP/R & D
Investor Email[email protected]; investorgrievances@pa
🌐 www.panaceabiotec.com

📍 Ambala-Chandigarh Highway, Lalru, Punjab, 140501

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search